We are live on ! Find out more
KRON

Kronos Bio
KRON

Delisted

KRON was delisted on the 20th of June, 2025.

Back to rankings

81 hedge funds and large institutions have $558M invested in Kronos Bio in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 16

4% more ownership

Funds ownership: 68.84% → 72.84% (+4%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

8% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 13

2% less funds holding

Funds holding: 83 → 81 (-2)

31% less capital invested

Capital invested by funds: $812M → $558M (-$254M)

Holders
81
Holders Change
-2
Holders Change %
-2.41%
% of All Funds
1.25%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
12
Increased
30
Reduced
16
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$12.9M
2
BlackRock
BlackRock
New York
+$6.84M
3
Cerity Partners
Cerity Partners
New York
+$6.17M
4
AG
Artal Group
Luxembourg
+$3.52M
5
SG Americas Securities
SG Americas Securities
New York
+$2.55M

Top Sellers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
-$18.8M
2
PAMS
Pictet Asset Management (Switzerland)
Switzerland
-$3.84M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$3.75M
4
HA
HHLR Advisors
Cayman Islands
-$3.22M
5
UBS AM
UBS AM
Illinois
-$2.99M
Name Holding Trade Value Shares
Change 		Change in
Stake
WP
26
Woodline Partners
California
$4.21M -$2.99M -191,031 -38%
CC
27
Commodore Capital
New York
$4.06M – – –
Charles Schwab
28
Charles Schwab
California
$3.89M +$87.2K +5,573 +2%
CIA
29
Choate Investment Advisors
Massachusetts
$3.83M -$1.75M -111,642 -28%
Morgan Stanley
30
Morgan Stanley
New York
$2.73M +$1.03M +65,522 +48%
SG Americas Securities
31
SG Americas Securities
New York
$2.53M +$2.55M +162,763 +697%
N
32
Nuveen
North Carolina
$2.52M +$45.1K +2,884 +2%
Goldman Sachs
33
Goldman Sachs
New York
$2.26M +$783K +50,071 +43%
BP
34
BBR Partners
New York
$2.22M – – –
Bank of New York Mellon
35
Bank of New York Mellon
New York
$1.88M +$40.7K +2,600 +2%
Deutsche Bank
36
Deutsche Bank
Germany
$1.69M +$1.59M +101,630 +445%
SB
37
Samsara BioCapital
California
$1.06M – – –
Rafferty Asset Management
38
Rafferty Asset Management
New York
$1.04M +$1.2M +76,468 New
Citigroup
39
Citigroup
New York
$945K +$1.01M +64,479 +1,278%
AA
40
ALPS Advisors
Colorado
$886K +$1.02M +65,212 New
TD Asset Management
41
TD Asset Management
Ontario, Canada
$744K – – –
Two Sigma Investments
42
Two Sigma Investments
New York
$720K +$515K +32,901 +164%
CBA
43
Coastal Bridge Advisors
Connecticut
$706K -$417K -26,667 -34%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$698K -$9.45K -604 -1%
State of Wisconsin Investment Board
45
State of Wisconsin Investment Board
Wisconsin
$682K – – –
UBS Group
46
UBS Group
Switzerland
$629K +$688K +44,000 +1,916%
Ameriprise
47
Ameriprise
Minnesota
$561K -$29.7K -1,900 -4%
AllianceBernstein
48
AllianceBernstein
Tennessee
$534K – – –
Swiss National Bank
49
Swiss National Bank
Switzerland
$504K – – –
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$478K +$6.84K +437 +1%
1
2
3 4

KRON Hedge Fund Activity: Q4 2021 in Review

81 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Kronos Bio (KRON) for Q4 2021, worth a combined $558M — down 31% from $812M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of KRON and 12 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 30 added.

The largest buyer was State Street, adding an estimated $12.9M. The largest seller was Capital Research Global Investors, exiting entirely with an estimated $18.8M sold.

  • 81 institutional investors held Kronos Bio (KRON) as of Q4 2021, down from 83 in Q3 2021.
  • Funds reported $558M of Kronos Bio stock for Q4 2021, down 31% quarter-over-quarter.
  • 12 funds opened new Kronos Bio positions in Q4 2021 and 13 closed out, a net change of -1 holder.
  • The largest Kronos Bio buyer in Q4 2021 was State Street, an estimated $12.9M added.
  • The largest Kronos Bio seller in Q4 2021 was Capital Research Global Investors, an estimated $18.8M sold.

Based on aggregated 13F filings for Q4 2021.